Cervical Cancer Screening Among Chinese Women Su-I Hou, DrPH, MPH, RN, CHES Assistant Professor, Health Promotion & Behavior, University of Georgia, Athens, GA Email: shou@uga.edu UT-Houston, School of Public Health Health Promotion / Health Education 1 Sponsor: Cheng Ching Hospital, Taichung, Taiwan Outline of the Presentation Specific Aims Introduction Significance Pilot Study and Instrument Validation Methods/Results/Summary Intervention Development Methods/Results/Summary Program Intervention Evaluation Methods/Results/Summary © Su-I Hou, DrPH, RN, CHES 2 Specific Aims 1. Pilot Study - To develop and validate study instruments To assess factors that influence Pap screening behavior among women in Taiwan 2. Develop and implement a theory and evidence based intervention using Intervention Mapping 3. Evaluate the effectiveness of the program intervention 3 © Su-I Hou, DrPH, RN, CHES Outcomes Primary Outcome Measures Pap screening rate Secondary Outcome Measures Perceived pros, perceived cons Susceptibility, perceived norms Knowledge of cervical cancer & Pap Covariates Demographics 4 © Su-I Hou, DrPH, RN, CHES Introduction Cervical Cancer 2nd most common cancer among women worldwide 1st most common cancer among women in Taiwan Incidence rate: 32.49/10,000 40% of the female deaths in Taiwan due to cancer 10% of these cancer deaths were due to cervical cancer 5 © Su-I Hou, DrPH, RN, CHES Risk Factors for Cervical Cancer Sexual activity before the age of 20 (Zhang & Chen, 1986) Multiple sexual partners (Cuzick et al, 1989 ; Parazzini et al, 1992) History of HPV / STDs (Kjaer et al, 1996) Smoking (Coker, 1992; Simons et al, 1993) History of abnormal Pap (Zhang & Chen, 1986) 6 © Su-I Hou, DrPH, RN, CHES Pap Screening Behavior Hiatt RA & Pasick R, 1995 (Bay area, SF) Prevalence of ever had a Pap: White/Black -- 98%; Latino -- 97%; Chinese -- 56% Wang PD & Lin RS, 1996 (Taipei, Taiwan) About 40+% of the women never had a Pap 86% had not had one in the past year Li CF & Zhou BS, 1997 (Kimen, Taiwan) Pap test prevalence: 62% (615 / 990) Annual Pap test compliance: 45% (274 / 615) © Su-I Hou, DrPH, RN, CHES 7 Factors Influencing Pap Screening Behavior Personal Factors Knowledge (Harlan ‘91; Jian ‘92; Kelly ‘96) Perceived susceptibility (Seow ‘95, Neilson ‘98) Perceived pros/cons (Pham ‘92; Seow ‘95; Yu ‘98, etc.) Perceived norms (Gotay ‘98) Demographics (Yi ‘94; Wang ‘96) External Factors Availability/Accessibility/Affordability (Wilcox ‘93) Social support (Li ‘91; Suarez ‘94; Burnett ‘95) Doctor-patient relationships (Pham ‘92; Yi ‘94) 8 © Su-I Hou, DrPH, RN, CHES Significance Data for Chinese women are limited National Health Insurance Plan provides women aged 30 and older to have an annual Pap test The significance of cervical cancer in Taiwan Few intervention programs targeting Chinese women and none were developed based on theory or evaluated properly 9 © Su-I Hou, DrPH, RN, CHES Pilot Study and Instrument Validation Method Sample: Female family members of patients admitted to ChengChing Hospital (CCH) during Feb.~ Mar. 1999 Measurement: Self administered questionnaire (prior screening experience; perceived pros/cons; perceived norms; susceptibility; knowledge; and demographics) Analysis: Compare screening participants v.s. non-participants; Chi-square test; log regression analysis 10 © Su-I Hou, DrPH, RN, CHES Pilot Study and Instrument Validation (con’t) Results Sample Characteristics (N=125) mean age: 38 Married: 90%* Work full time: 62% > College education: 32% Scale Reliability Perceived pros: Perceived cons: Perceived norms: Susceptibility: Knowledge: (p=.03) Chronbach 0.88 (11 items) 0.68 ( 9 items) 0.72 ( 4 items) 0.68 ( 2 items) 0.70 (16 items) Items with low CITC (corrected-item-total corr.) were re-evaluate for their appropriateness 11 © Su-I Hou, DrPH, RN, CHES Pilot Study and Instrument Validation (con’t) Logistic regression Analysis Adjusted for Marital Status Scales Odds Ratio 95% CI P-Value Pros 1.08 (1.00, 1.16) 0.04* Cons 0.87 (0.80, 0.95) 0.00* Norms 1.25 (1.04, 1.50) 0.02* Knowledge 1.14 (1.01, 1.30) 0.03* 12 © Su-I Hou, DrPH, RN, CHES Pilot Study and Instrument Validation (con’t) Summary & Limitations It provided a basis for measuring factors associated with Pap screening behavior among Chinese women. The pilot study helped define the approach of further needs assessment and intervention development. Larger studies are required to further examine the relationships of these potential influencing factors and 13 screening behavior. Intervention Development Methods Intervention Development Process IM Step 1: Proximal Program Objectives IM Step 2: Methods and Strategies IM Step 3: Designing and Organizing Programs IM Step 4: Adoption and Implementation Plans IM Step 5: Generating an Evaluation Plan Needs Assessment Quantitative results from pilot study Qualitative data from focus groups Existing social and behavior science theories Findings from previous studies © Su-I Hou, DrPH, RN, CHES 14 Intervention Development (con’t) IM Step 1: Proximal Program Objectives Behavior - Non-compliant women will obtain a Pap after the intervention PO1: schedule a Pap test PO2: obtain a Pap test Personal determinants: intention; knowledge; perceived pros/cons; perceived norms; susceptibility External determinants: cues to action Environments - Increased availability of alternative service by female doctors PO1: hospital administrators approve provision of service PO2: female Drs. sign up to perform Pap exams in the community Personal determinants: External determinants: © Su-I Hou, DrPH, RN, CHES knowledge; outcome expectations reward / compensation 15 Intervention Development (con’t) IM Step 2: Methods and Strategies Learning Objectives Methods Knowledge determinate LO Information Direct mail Brochure transmission communication Fact Sheet Intention, perceived Modeling pros/cons; perceived norms; & susceptibility Persuasion determinate LO Cue to action / Facilitation availability of alternative service © Su-I Hou, DrPH, RN, CHES Strategies Testimonial descriptions Persuasive communication Enabling services Reminders Increase availability Components Role model stories Quotes from women Phone calls Reminding letter Screening service 16 Intervention Development (con’t) IM Step 3: Designing and Organizing Programs Program Theme: “Love yourself before you take care of your family” Scope and Sequence of the program: 1st month - personalized welcome letter cervical cancer/Pap brochure quotes of other women’s experience screening schedule w/ doctors information 2nd month - personalized screening invitation letter screening service provided by female doctor role model stories knowledge-based fact sheet updated screening schedule 3rd month - phone intervention (reminder calls) reminding letters © Su-I Hou, DrPH, RN, CHES 17 18 © Su-I Hou, DrPH, RN, CHES Intervention Development (con’t) IM Step 4: Adoption and Implementation Plans PO1: program sponsor approves the intervention program PO2: obtain a list of non-compliant women PO3: schedule and mail the intervention materials to women PO4: co-ordinate community screening services with female doctors PO5: conduct screening reminding calls Personal determinants: behavior capability; outcome expectations External determinants: reward / compensation Training sessions: recruiting and identifying non-compliant women schedule and send program materials conducting screening reminding calls 19 © Su-I Hou, DrPH, RN, CHES Intervention Development (con’t) IM Step 5: Generating an Evaluation Plan Pretest - Posttest Control Group R R O1 O1 X O2 (3 mon. after O1) O2 (3 mon. after O1) where R= random assignment ============================================== post-test (O2) pre-test (O1) Demographics Previous screening experience Screening behavior Beliefs Beliefs Knowledge Knowledge Intervention components 20 © Su-I Hou, DrPH, RN, CHES Intervention Development (con’t) Summary & Future Directions By using the IM process, we were able to systematically incorporate empirical and new data, as well as utilize theories to guide the intervention design. The needs assessment provided an important foundation of the program. IM helped us ensure addressing factors associated with screening behavior in the program development. The framework also helped us in developing the evaluation questions. Programs targeting other health related behavior, or using other methods/strategies can be developed with this IM process as 21 well. Program Intervention Evaluation Method Sample: Female family members of patients who admitted in the CCH during Aug.~Sep. 1999 (N=424) Inclusion Criteria: Married women or aged 30+, non-compliant to Pap screening (no Pap in the past 12 months), no hysterectomy, not pregnant Analysis: Compare study outcomes between women in intervention and comparison groups pre- & post- changes within groups © Su-I Hou, DrPH, RN, CHES 22 Program Intervention Evaluation (con’t) Results (N=424) Sample Characteristics & Group Comparisons (Baseline) mean age: Married: Work full time: > College education: 34 89% 40% 28% P=.227 p=.532 p=.777 p=.195 Prior screening (ever) Intention 58% p=.168 63% p=.422 Women in the study were randomly assigned to each group very 23well. © Su-I Hou, DrPH, RN, CHES Program Intervention Evaluation (con’t) Comparisons of Scale Means (Baseline) Scales Knowledge (16 items) Pros (13 items) Cons (13 items) Norms (4 items) Susceptibility (3 items) Intervention Comparison All (N=212) (N=212) (N=424) P-Value (T-test) 0.77 0.74 0.76 0.103 4.17 4.17 4.17 0.978 2.77 2.79 2.78 0.748 3.90 3.95 3.92 0.320 2.81 2.84 2.83 0.678 24 © Su-I Hou, DrPH, RN, CHES Program Intervention Evaluation (con’t) Pap Completion Rate Intervention Group: Comparison Group: 0% 0% 51% 32% P=0.002* 89% 93% btw groups P=0.310 Pap Intention (Pre-contemplators) Intervention Group: Comparison Group: 0% 0% within groups P=0.000* Pap Intention (Contemplators) Intervention Group: 62% obtain a Pap Comparison Group: 38% obtain a Pap P=0.008* 25 © Su-I Hou, DrPH, RN, CHES Program Intervention Evaluation (con’t) Comparisons of Scale Means (Follow-up) Scales Intervention (N=123) Comparison (N=124) P-Value (Adjusted) Knowledge 0.82 0.79 0.305 Pros 4.26 4.16 0.031* Cons 2.65 2.75 0.059 Norms 3.88 3.90 0.880 Susceptibility 2.96 2.92 0.447 Linear reg. were used for the follow-up group comparisons to 26 adjust pretest scale and intervention effects © Su-I Hou, DrPH, RN, CHES Program Intervention Evaluation (con’t) Changes in Scales Within Groups Over Time (pre- & post-test) Scales Intervention Mean Knowledge 0.04 P-value Comparison (paired-t) Mean 0.016* 0.03 P-value (paired-t) 0.020* Pros 0.09 0.008* -0.01 0.838 Cons -0.08 0.076 0.03 0.472 Norms 0.00 0.961 -0.03 0.470 Susceptibility 0.13 0.011* 0.08 0.101 27 © Su-I Hou, DrPH, RN, CHES Program Intervention Evaluation (con’t) Limitations & Future Directions Limitations: The generalization of the results Future Directions: Program designed to address factors associated with screening behavior can result an effective intervention for the specific population Future program can consider similar strategies for reaching at-risk population Future studies should further investigate the role of pros/cons on influencing cancer screening behavior 28 Pilot Study Publications related to this project Hou, S., Fernandez, M., Baumler, E., Parcel, G, & Chen P. (2003). Correlates of cervical cancer screening among women in Taiwan. Health Care for Women International, 24 (5), 384-398. Intervention Development Hou, S., Fernandez, M., & Parcel, G. (2004). Development of a cervical cancer educational program for Chinese women using Intervention Mapping. Health Promotion Practice, 5(1), 80-87. Evaluation Study Hou, S., Fernandez, M., Baumler, E., & Parcel G. (2002). Effectiveness of an intervention to increase Pap test screening among Chinese women in Taiwan. Journal of Community Health, 27(4), 277-290. Instrument Development Hou, S., Luh, W., & Chen, P. (in press). Psychometric properties of the Cervical Smear Belief Inventory for Chinese women. International Journal of Behavior Medicine. 29 30 Su-I Hou (sweet)